Open Access
POINT-COUNTERPOINT DEBATE
POINT: It's never too soon
University of Maryland Greenebaum Cancer Center, School of Medicine, Baltimore, Maryland, USA
Address correspondence to Nancy A. Dawson, MD, 22
S. Greene Street, Suite# S9D13, Baltimore, Maryland 21201
Canadian Journal of Urology 2003, 10(6), 2036-2037.
Abstract
A multidisciplinary approach to prostate cancer has become the rule and not the exception. Involving the entire team, which includes a medical oncologist, from the time of initial diagnosis is optimal. This facilitates maximal patient education regarding treatment options and enhances informed decision making.A coordinated approach also promotes enrollment on clinical trials, which are often, multimodality, especially in high-risk early stage prostate cancer. Integrated therapeutic strategies throughout the patient's disease course can improve both patient care and satisfaction.
Keywords
Cite This Article
Copyright © 2003 The Author(s). Published by Tech Science Press.This work is licensed under a Creative Commons Attribution 4.0 International License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


Submit a Paper
Propose a Special lssue
Download PDF
Downloads
Citation Tools